Concepedia
Statistics
Publications
2
Citations
112
H-Index
Active since
2019
Affiliations
vTv Therapeutics (United States)(Current)
University of North Carolina at Chapel Hill
Jennifer L. R. Freeman is an author at vTv Therapeutics (United States).
Publications per year
2019–2021
Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator
Adrian Vella, Jennifer L. R. Freeman, Imogene Dunn et al. · Science Translational Medicine · 2019 · 73 citations
The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes
Klara R. Klein, Jennifer L. R. Freeman, Imogene Dunn et al. · Diabetes Care · 2021 · 39 citations · Full text
1–2 of 2